Posttransplant lymphoproliferative disorder:: Morphological picture and diagnostic difficulties

被引:21
作者
Ziarkiewicz-Wróblewska, B
Górnicka, B
Suleiman, W
Oldakowska-Jedynak, U
Wróblewski, T
Bogdanska, M
Ziólkowski, J
Nowacka-Cieciura, E
Foroncewicz, B
Pileri, SA
Durlik, M
Paczek, L
Krawczyk, M
Wasiutynski, A
机构
[1] Warsaw Med Univ, Dept Pathol, PL-02106 Warsaw, Poland
[2] Warsaw Med Univ, Dept Gen Transplant & Liver Surg, Warsaw, Poland
[3] Warsaw Med Univ, Dept Transplant Med & Nephrol, Warsaw, Poland
[4] Warsaw Med Univ, Inst Transplantat, Dept Immunol Transplantol & Internal Dis, Warsaw, Poland
[5] Univ Bologna, Sch Med, Chair Pathol Anat, Bologna, Italy
[6] Univ Bologna, Sch Med, Unit Haematopathol, Bologna, Italy
[7] Univ Bologna, Sch Med, Inst Haematol & Clin Oncol, Bologna, Italy
关键词
D O I
10.1016/j.transproceed.2005.12.072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Posttransplant lymphoproliferative disorder (PTLD) is a well-known complication of both solid organ and bone marrow transplantation. It includes a wide spectrum of proliferative changes ranging from reactive hyperplasia, borderline lesions to malignant lymphomas. PTLD develops in 1% to 10% of transplant recipients. We present 10 cases of PTLD. Five developed after renal, four after liver, and one after heart transplantation. Among the early lesions, we diagnosed two reactive plasmacytic hyperplasias; one infectious mononucleosis-like PTLD; one polymorphic lesion; and one "mixed" case of plasmacytic hyperplasia in one tonsil with a polymorphic PTLD in the second one. Among the lymphomas, we observed three diffuse large B-cell lymphoma (DLBCL); one mantle lymphoma; and one Hodgkin lymphoma-like PTLD. The morphological pictures of six PTLD cases were typical and posed no diagnostic problems. In the one case of plasmacytic hyperplasia, the lymph node morphology was atypical with atrophy of lymphoid components accompanying plasma cell proliferation. Contrary to a good prognosis of early, reactive PTLD, this patient experienced a rapid course and succumbed to sepsis. The most difficult case was a rare Hodgkin lymphoma-like PTLD, which was diagnosed only by a bone marrow biopsy. Because of its noncharacteristic immunophenotype, it was primarily diagnosed as an anaplastic lymphoma of the T-cell type. After additional immunohistochemical studies (BOB and OCT2), we established the final diagnosis of Hodgkin lymphoma-like PTLD. Due to the increasing number of organ transplantations, doctors of various specialties may encounter PTLD.
引用
收藏
页码:168 / 172
页数:5
相关论文
共 28 条
[1]   Neoplasia in solid organ transplant recipients: Single-center experience [J].
Alvarez, A ;
Sanroman, B ;
Carro, E ;
Vazquez-Martul, E .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) :784-786
[2]  
Angel L F, 2000, Ann Transplant, V5, P26
[3]  
[Anonymous], 2001, Tumours of the Haematopoietic and Lymphoid Tissues
[4]   High grade lymphoma in a post-renal transplant patient - Description of a case and literature review [J].
Bustillo, M ;
Melon, CP ;
Glz, AO ;
Esteban, E ;
Armada, E ;
Bello, JA ;
Sastre, JL .
NEPHRON, 2000, 84 (02) :189-191
[5]   Post-transplant Lymphoproliferative disorder in the United States: Young Caucasian males are at highest risk [J].
Dharnidharka, VR ;
Tejani, AH ;
Ho, PL ;
Harmon, WE .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (10) :993-998
[6]   Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases? [J].
Ghobrial, IM ;
Habermann, TM ;
Macon, WR ;
Ristow, KM ;
Larson, TS ;
Walker, RC ;
Ansell, SM ;
Gores, GJ ;
Stegall, MD ;
McGregor, CG .
TRANSPLANTATION, 2005, 79 (02) :244-247
[7]   A single-centre experience of post-renal transplant lymphoproliferative disorder [J].
Herzig, KA ;
Juffs, HG ;
Norris, D ;
Brown, AM ;
Gill, D ;
Hawley, CM ;
Cobcroft, R ;
Petrie, JB ;
Marlton, P ;
Thomson, D ;
Campbell, SB ;
Nicol, DL ;
Johnson, DW .
TRANSPLANT INTERNATIONAL, 2003, 16 (07) :529-536
[8]   Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation [J].
Hézode, C ;
Duvoux, C ;
Germanidis, G ;
Roudot-Thoraval, F ;
Vincens, AL ;
Gaulard, P ;
Cherqui, D ;
Pawlotsky, JM ;
Dhumeaux, D .
HEPATOLOGY, 1999, 30 (03) :775-778
[9]  
Hoshida Y, 2001, INT J CANCER, V91, P869, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO
[10]  
2-N